The kinetics of the antibody response was also evaluated. This study aims at assessing the analytical and clinical performance of the iFlash® anti-SARS-CoV-2 chemiluminescence assay for the detection of both IgM and IgG antibodies. Electronic address: serological SARS-CoV-2 immunoassays have been developed recently but require external validation before widespread use. 7 Department of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Belgium Qualiblood sa, Namur, Belgium.6 Department of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Belgium.5 Department of Laboratory Medicine, Saint Nikolaus Hospital, Eupen, Belgium.4 Department of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Belgium Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium.3 Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.2 Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium Department of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Belgium.1 Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Université catholique de Louvain, Brussels, Belgium.
0 kommentar(er)
